Lalitsiri Atti, MBBS
- Part D claims, 2024
- 395
- Publications
- 17
- Industry payments
- $422
- State license
- 1
- Year NPI issued
- 2023
- Practice address
- 1215 E Michigan Ave, Lansing, MI 48912
- Practice phone
- Call (517) 364-6000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
UM Health-Sparrow Lansing Campus
Lansing, Michigan
Find Lalitsiri Atti's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Lalitsiri Atti is an internist in Lansing, Michigan
Lalitsiri Atti practices at UM Health-Sparrow Lansing Campus in Lansing, Michigan.
Lalitsiri Atti's NPI, 1639858889, was assigned on July 14, 2023. Lalitsiri Atti holds Michigan license 4351051411.
- NPI
- 1639858889NPI Registry (opens in a new tab)
- NPI enumeration date
- July 14, 2023
- NPI status
- Active
- Practice phone
- (517) 364-6000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Lalitsiri Atti practices at UM Health-Sparrow Lansing Campus in Lansing, Michigan
Lalitsiri Atti's primary practice is UM Health-Sparrow Lansing Campus, at 1215 E Michigan Ave, Lansing, MI 48912 in Ingham County. The practice phone is (517) 364-6000.
- UM Health-Sparrow Lansing Campus1215 E Michigan Ave, Lansing, MI 48912 · Ingham CountyPhone(517) 364-6000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Lalitsiri Atti is affiliated with 1 site of care
Lalitsiri Atti's primary practice is UM Health-Sparrow Lansing Campus in Lansing, Michigan.
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Lalitsiri Atti's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Lalitsiri Atti practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| UM Health-Sparrow Lansing Campus | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Lalitsiri Atti is one of 4,804 internists in Michigan
Internal medicine is Lalitsiri Atti's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Lalitsiri Atti is licensed in Michigan.
Specialties and state licenses
- Internal medicine, MichiganPrimary
Internists near Lalitsiri Atti
Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Lalitsiri Atti's patients have a median age of 43
Across all payers, Dmand AI patient panel data puts Lalitsiri Atti's median patient age at 43, with 20% women.
Lalitsiri Atti's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 43
Patient panel by sex, all payers
- Women20%
- Men80%
Source: Dmand AI Patient Panel Data
Lalitsiri Atti wrote 395 Medicare Part D claims in 2024
In 2024, Lalitsiri Atti wrote 395 Medicare Part D claims for 72 patients. 84% of them were for generic drugs. CMS names the drug for 129 of them, across 8 drugs with 11 or more claims each, at $11,534 in total drug cost.
Lalitsiri Atti's Part D claims by kind of drug, 2024
- Generic332 claims84%
- Brand-name63 claims16%
Lalitsiri Atti's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Lalitsiri Atti's Part D claims, 2024
- Opioids6%23 of 395 claims
- Antibiotics4%17 of 395 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Lalitsiri Atti has 17 publications on record
Dmand AI links 17 papers to Lalitsiri Atti, published from 2020 to 2025. 2023 was the busiest year, with 7. The most frequent topics are COVID-19, Inpatients and Heart Failure. Lalitsiri Atti has published most often in Am J Cardiol. Lalitsiri Atti's most frequent co-authors are Shafaqat Ali, MD, M. Chadi Alraies, MD and Karthik Gonuguntla, MD.
Lalitsiri Atti's papers by year, 2020 to 2025
Topics Lalitsiri Atti writes about most
- COVID-19
- Inpatients
- Heart Failure
- Hospital Mortality
- Myocardial Infarction
- Patient Readmission
- Stroke
Lalitsiri Atti's most frequent co-authors
- Shafaqat Ali, MD8 shared papers
- M. Chadi Alraies, MD5 shared papers
- Karthik Gonuguntla, MD5 shared papers
Recent publications by Lalitsiri Atti
See who Lalitsiri Atti researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Lalitsiri Atti works with, so you can find a warm path to the right internists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Lalitsiri Atti received $422 in industry payments from 2024 to 2025
CMS Open Payments shows 17 general payments to Lalitsiri Atti from 12 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $64.
General payments to Lalitsiri Atti by program year, 2024 to 2025
Companies that paid Lalitsiri Atti the most, 2024 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Lalitsiri Atti's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Lalitsiri Atti
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Lalitsiri Atti's NPI number?
Lalitsiri Atti's NPI number is 1639858889. It was assigned on July 14, 2023, and it is active in the NPI Registry.
What does Lalitsiri Atti specialize in?
Lalitsiri Atti is an internist in Lansing, Michigan. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).
Where does Lalitsiri Atti practice?
Lalitsiri Atti practices at 1215 E Michigan Ave, Lansing, MI 48912. Lalitsiri Atti's primary practice is UM Health-Sparrow Lansing Campus in Lansing, Michigan.
What is Lalitsiri Atti's office phone number?
The practice phone on file for Lalitsiri Atti is (517) 364-6000.
What is Lalitsiri Atti's medical license number?
Lalitsiri Atti holds Michigan license 4351051411.
What drugs does Lalitsiri Atti prescribe most?
In 2024 Medicare Part D data, Lalitsiri Atti's most prescribed drugs by claims were Atorvastatin Calcium, Eliquis and Tramadol HCl.
Has Lalitsiri Atti received payments from drug or device companies?
CMS Open Payments shows $422 in general payments to Lalitsiri Atti from 12 companies from 2024 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Lalitsiri Atti been practicing?
Lalitsiri Atti's NPI was assigned in 2023.
Does Lalitsiri Atti do research?
Dmand AI links 17 publications to Lalitsiri Atti, published from 2020 to 2025.
Who does Lalitsiri Atti publish with?
Lalitsiri Atti's most frequent co-authors are Shafaqat Ali, MD (8 shared papers), M. Chadi Alraies, MD (5 shared papers) and Karthik Gonuguntla, MD (5 shared papers).
Selling to internal medicine practices?
See internists in Michigan by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card